Cite

HARVARD Citation

    Toss, M. et al. (2020). Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ. Journal of clinical pathology. 73 (2), pp. 76-82. [Online]. 
  
Back to record